X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (320) 320
melanoma-associated antigen (197) 197
oncology (172) 172
melanoma (163) 163
animals (144) 144
index medicus (128) 128
immunotherapy (116) 116
female (103) 103
immunology (96) 96
male (86) 86
mice (86) 86
cancer (85) 85
melanoma-associated antigens (85) 85
antigens (83) 83
melanoma - immunology (78) 78
expression (77) 77
antigens, neoplasm - immunology (62) 62
middle aged (62) 62
melanoma-associated retinopathy (59) 59
tumors (58) 58
aged (55) 55
biochemistry & molecular biology (53) 53
cell biology (53) 53
metastatic melanoma (51) 51
adult (49) 49
medicine, research & experimental (49) 49
melanoma-specific antigens (48) 48
tumor cells, cultured (48) 48
immunohistochemistry (45) 45
proteins (45) 45
identification (44) 44
monoclonal-antibodies (42) 42
neoplasm proteins - genetics (41) 41
neoplasm proteins - metabolism (40) 40
antigens, neoplasm (39) 39
antigen (38) 38
cell line, tumor (38) 38
gene expression (38) 38
neoplasms - immunology (38) 38
melanoma - pathology (37) 37
dendritic cells (36) 36
molecular sequence data (36) 36
cells (35) 35
lymphocytes (34) 34
melanoma-associated antigen-p97 (34) 34
neoplasms - therapy (33) 33
antigens, neoplasm - genetics (32) 32
antigens, neoplasm - metabolism (32) 32
cancer-associated retinopathy (32) 32
pathology (32) 32
prognosis (32) 32
protein (31) 31
research (30) 30
t-lymphocytes, cytotoxic - immunology (30) 30
antibodies (29) 29
apoptosis (29) 29
flow cytometry (29) 29
amino acid sequence (28) 28
malignant-melanoma (28) 28
ophthalmology (28) 28
in-vivo (27) 27
neoplasm proteins - immunology (27) 27
autoantibodies (26) 26
autoimmunity (26) 26
metastasis (26) 26
aged, 80 and over (25) 25
biotechnology & applied microbiology (25) 25
cancer vaccines - immunology (25) 25
care and treatment (25) 25
tumor-infiltrating lymphocytes (25) 25
article (24) 24
breast-cancer (24) 24
health aspects (24) 24
antibodies, monoclonal - immunology (23) 23
cancer vaccines (23) 23
dermatology (23) 23
genetic aspects (23) 23
monoclonal-antibody (23) 23
analysis (22) 22
melanoma - genetics (22) 22
melanoma - therapy (22) 22
mice, inbred balb c (22) 22
neoplasms (22) 22
polymerase chain reaction (22) 22
vaccines (22) 22
gene expression regulation, neoplastic (21) 21
melanoma-associated ganglioside (21) 21
mice, inbred c57bl (21) 21
patients (21) 21
reverse transcriptase polymerase chain reaction (21) 21
t-lymphocytes - immunology (21) 21
transfection (21) 21
vaccination (21) 21
antigens, neoplasm - analysis (20) 20
dendritic cells - immunology (20) 20
immunotherapy - methods (20) 20
cancer therapies (19) 19
cell line (19) 19
development and progression (19) 19
medicine (19) 19
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 11/2014, Volume 10, Issue 11, pp. 3332 - 3346
Vaccines targeting pathogens are generally effective and protective because based on foreign non-self antigens which are extremely potent in eliciting an... 
tumor-associated antigens | MS, mass spectrometry | HLA, human leukocyte antigen | PAP, prostatic acid phosphatase | APCs, antigen-presenting cell | DCs, dendritic cells | cancer vaccine | Ig Id, immunoglobulin idiotype | EGT, electro-gene-transfer | PRRs, Pattern Recognition Receptors | MVA, modified vaccinia strain Ankara | GB, glioblastoma | RCR, renal cell cancer | CDCA1, cell division cycle associated 1 | TLRs, Toll-Like Receptors | CTL, cytotoxic T-lympocites | BCG, Bacille Calmette-Guerin | TARP, T-cell receptor gamma alternate reading frame protein | hTERT, human Telomerase reverse transcriptase | IFNg, interferon gamma | clinical trials | CRC, colorectal cancer | SSX-2, Synovial sarcoma X breakpoint 2 | PSA, Prostate-specific antigen | GM-CSF, granulocyte macrophage-colony stimulating factor | TACAs, Tumor-associated carbohydrate antigens | MHC, major histocompatibility complex | TAAs, tumor-associated antigens | HPV, human papillomavirus | WGS, whole genome sequencing | NSCLC, non-small-cell lung carcinoma | epitopes | MAGE-A1, Melanoma-associated antigen 1 | LPs, long peptides | WES, whole exome sequencing | FDA, Food & drug administration | BCR, B-cell receptor | CT, Cancer-testis | HSPs, stress/heat shock proteins | HER2, human epidermal growth factor receptor 2 | immunotherapeutics | TPA, transporter associated with antigen processing | mCRPC, metastatic castrate-resistant prostate cancer | Clinical trials | Immunotherapeutics | Cancer vaccine | Epitopes | Tumor-associated antigens | T-cell receptor gamma alternate reading frame protein | WGS | MHC | cytotoxic T-lympocites | major histocompatibility complex | IMMUNOLOGY | granulocyte macrophage-colony stimulating factor | mCRPC | Toll-Like Receptors | METASTATIC MELANOMA | dendritic cells | IFNg | GM-CSF | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | electro-gene-transfer | PSA | modified vaccinia strain Ankara | colorectal cancer | interferon gamma | PULSED DENDRITIC CELLS | human Telomerase reverse transcriptase | SSX-2 | human leukocyte antigen | MS | BCG | prostatic acid phosphatase | cell division cycle associated 1 | whole exome sequencing | whole genome sequencing | immunoglobulin idiotype | BCR | Cancer-testis | glioblastoma | ACTIVE SPECIFIC IMMUNOTHERAPY | DNA VACCINES | CRC | human papillomavirus | MVA | non-small-cell lung carcinoma | hTERT | HLA | Tumor-associated carbohydrate antigens | RCR | FDA | CDCA1 | antigen-presenting cell | WES | TPA | Prostate-specific antigen | PRRs | Bacille Calmette-Guerin | B-cell receptor | transporter associated with antigen processing | TARP | metastatic castrate-resistant prostate cancer | CYTOTOXIC T-LYMPHOCYTES | HSPs | HPV | MHC CLASS-I | HEAT-SHOCK PROTEINS | PHASE-II TRIAL | DCs | TAAs | mass spectrometry | GB | long peptides | APCs | stress | renal cell cancer | NSCLC | Ig Id | human epidermal growth factor receptor 2 | Food & drug administration | LPs | CT | EGT | TUMOR-CELL VACCINE | Melanoma-associated antigen 1 | TACAs | Synovial sarcoma X breakpoint 2 | MAGE-A1 | Pattern Recognition Receptors | CTL | HER2 | heat shock proteins | TLRs | PAP | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Antigens, Neoplasm - immunology | Neoplasms - immunology | Humans | Adjuvants, Immunologic - therapeutic use | Precision Medicine | Tumor Escape - immunology
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 12/2015, Volume 64, Issue 12, pp. 1623 - 1635
Journal Article
Chinese Medical Journal, ISSN 0366-6999, 06/2018, Volume 131, Issue 11, pp. 1289 - 1295
Journal Article
ONCOIMMUNOLOGY, ISSN 2162-4011, 09/2014, Volume 3, Issue 9, p. e954919
Immunotherapy is a promising treatment option for patients with hepatocellular carcinoma (HCC). Indeed, CD8(+) T-cell responses against various tumor antigens... 
tumor-associated antigens | SAFETY | melanoma | ANTIBODY | IMMUNOLOGY | CANCER | regulatory T cells | TRIAL | RESPONSES | ONCOLOGY | immunotherapy | CD8(+) T cells | PD-1 | T-cell failure | hepatocellular carcinoma | ADOPTIVE IMMUNOTHERAPY
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0124094
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 06/2011, Volume 34, Issue 5, pp. 448 - 456
The immunostimulatory capacity of dendritic cells is improved by co-electroporation with mRNA encoding CD40 ligand, constitutively active toll-like receptor 4,... 
melanoma | interferon alpha-2b | dendritic cell | immunotherapy | TriMix | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | METAANALYSIS | GUIDELINES | INTERLEUKIN-12 | IMMUNOLOGY | CD8(+) T-CELLS | METASTATIC MELANOMA | STAGE-IV MELANOMA | ONCOLOGY | HIGH-DOSE INTERFERON-ALPHA-2B | ANTIGEN | RNA, Messenger - immunology | Skin Neoplasms - drug therapy | Dendritic Cells - immunology | Humans | Middle Aged | Vaccination | Male | Recombinant Proteins | RNA, Messenger - metabolism | Hypersensitivity, Delayed - immunology | CD40 Antigens - metabolism | Skin Neoplasms - mortality | CD27 Ligand - metabolism | Adult | Female | Histocompatibility Antigens Class II - metabolism | Dendritic Cells - metabolism | CD27 Ligand - immunology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antigens, Neoplasm - immunology | Cancer Vaccines - administration & dosage | Melanoma | Electroporation | Toll-Like Receptor 4 - immunology | Toll-Like Receptor 4 - metabolism | Interferon-alpha - administration & dosage | Cancer Vaccines - immunology | Drug Therapy, Combination - methods | Histocompatibility Antigens Class II - immunology | Survival Analysis | Aged | Dendritic Cells - cytology | Neoplasm Staging | CD40 Antigens - immunology | CD40 antigen | Hypersensitivity (delayed) | Clinical trials | mRNA | Vaccines | CD70 antigen | Metastases | Lymphocytes | Immunotherapy | Toll-like receptors | Immunostimulation | Dendritic cells | Melanoma-associated antigen | Interleukin 12 | Monophenol monooxygenase | TLR4 protein | Disease control | Fever | Immunogenicity | Biopsy | Histocompatibility antigen HLA | Skin | Glycoprotein gp100 | Cancer
Journal Article
Journal of Cancer Research and Therapeutics, ISSN 0973-1482, 07/2018, Volume 14, Issue 5, pp. 1059 - 1064
Journal Article
Journal Article
International journal of nanomedicine, ISSN 1178-2013, 2014, Volume 9, pp. 5231 - 5246
Journal Article